ZZU-iPS-Normal-001
ZZUi011-A
General#
Cell Line |
|
| hPSCreg Name | ZZUi011-A |
| Alternative name(s) |
ZZU-iPS-Normal-001
|
| Cell line type | Human induced pluripotent stem cell (hiPSC) |
| Last update | 13th December 2017 |
| User feedback | |
Provider |
|
| Generator | Zheng Zhou University - The first affiliated hospital (ZZU) |
| Owner | Zheng Zhou University - The first affiliated hospital (ZZU) |
| Derivation country | China |
External Databases |
|
| BioSamples | SAMEA104620781 |
| Cellosaurus | CVCL_VE21 |
General Information |
|
| Publications | |
| Is the cell line available in principle? | Available with restrictions: Available for non-commercial research |
Donor Information#
General Donor Information |
|
| Sex | male |
| Ethnicity | Han |
Phenotype and Disease related information (Donor) |
|
| Diseases | No disease was diagnosed.
|
| Disease associated phenotypes | no phenotypes |
Karyotyping (Donor) |
|
| Has the donor karyotype been analysed? |
No
|
Other Genotyping (Donor) |
|
| Is there genome-wide genotyping or functional data available? |
No
|
External Databases (Donor) |
|
| BioSamples | SAMEA104620782 |
Ethics#
We are currently revising this section.hIPSC Derivation#
General |
|
| Source cell type |
Kidney Tubules |
| Source cell origin |
urineExcretion that is the output of a kidney
|
| Source cell type (free text) | Kidney tubules epithelial cells |
| Age of donor (at collection) | 25-29 |
| Collected in | 2016 |
| Passage number reprogrammed | P3 |
Reprogramming method |
|
| Vector type | Non-integrating |
| Vector | Sendai virus |
| Genes | |
| Is reprogramming vector detectable? |
No |
| Methods used |
RT-PCR
|
| Files and images showing reprogramming vector expressed or silenced | |
Vector free reprogramming |
|
| Type of used vector free reprogramming factor(s) |
None
|
Other |
|
| Selection criteria for clones | These colonies will consist of iPSCs, which exhibit a hESC-like morphology characterized by a flatter cobblestone-like appearance with individual cells clearly demarcated from each other in the colonies. |
| Derived under xeno-free conditions |
Yes |
| Derived under GMP? |
No |
| Available as clinical grade? |
No |
Culture Conditions#
| Surface coating | Vitronectin | |||||||||
| Feeder cells |
No |
|||||||||
| Passage method |
Enzyme-free cell dissociation
Gentle Cell Dissociation Reagent
|
|||||||||
| O2 Concentration | 95 % | |||||||||
| CO2 Concentration | 5 % | |||||||||
| Medium |
TeSR™ E8™
Supplements
|
|||||||||
| Has Rock inhibitor (Y27632) been used at passage previously with this cell line? | No |
|||||||||
| Has Rock inhibitor (Y27632) been used at cryo previously with this cell line? | No |
|||||||||
| Has Rock inhibitor (Y27632) been used at thaw previously with this cell line? | No |
Characterisation#
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | FACS | Enzymatic Assay | Expression Profiles |
| POU5F1 (OCT-4) |
Yes |
|
||||
| SOX2 |
Yes |
|
||||
| TRA 1-60 |
Yes |
|
Differentiation Potency
Microbiology / Virus Screening |
|
| HIV 1 | Negative |
| HIV 2 | Negative |
| Hepatitis B | Negative |
| Hepatitis C | Negative |
| Mycoplasma | Negative |
Genotyping#
Karyotyping (Cell Line) |
|
| Has the cell line karyotype been analysed? |
Yes
|
Other Genotyping (Cell Line) |
|
Login to share your feedback, experiences or results with the research community.